Skip to main content

Geoffrey DUSHEIKO

MD, MB, BCh, Professor of medicine at the Royal Free Hospital and University College London School of Medicine, consultant hepatologist at King’s College Hospital, London, UK

UK
City: London
Institution: Kings College Hospital

Geoffrey DUSHEIKO, MD, MB, BCh, is an emeritus professor of medicine at the Royal Free Hospital and University College London School of Medicine as well as a consultant hepatologist at King’s College Hospital, London, UK.

He earned his Bachelor of Medicine, Bachelor of Surgery degree from the University of Witwatersrand in Johannesburg, South Africa. After graduating, he completed his internship at Chris Hani Baragwanath Hospital in Johannesburg and his residency at Johannesburg Hospital. His fellowships were conducted at the Johannesburg Hospital Liver Unit, the National Institutes of Health (MD, USA), and the University of Minnesota (MN, USA).

Prof. DUSHEIKO’s research interests include the management and treatment of HCV, HBV, and small hepatocellular carcinoma. He has a special interest in research on viral hepatitis, particularly viral genotyping, applied molecular virology, the natural history of chronic viral hepatitis, and antiviral therapies. A member of several organisations, including EASL, AASLD, and the International Association for the Study of the Liver (IASL), Prof. Dusheiko is also a fellow of the Royal College of Physicians, the Royal College of Physicians of South Africa, and the Royal College of Physicians of Edinburgh. He served as educational councillor on the Governing Board of EASL for 4 years and was the recipient of the EASL Recognition Award in 2014.

In addition to being on the editorial board of the Journal of Viral Eradication, he is co-editor of Alimentary Pharmacology and Therapeutics and he has previously served on editorial boards for the Journal of Viral Hepatitis, Hepatology, Best Practice & Research: Clinical Gastroenterology, and Gut, among others. Prof. Dusheiko has authored or co-authored more than 400 articles published in international peer-reviewed journals or books. He has served as interim Deputy Director Hepatitis HIV STI and Blood Safety Division Public Health England.